Open Access. Powered by Scholars. Published by Universities.®

Physical Sciences and Mathematics Commons

Open Access. Powered by Scholars. Published by Universities.®

Nova Southeastern University

Chemistry and Physics Faculty Articles

Chemistry

2018

Articles 1 - 2 of 2

Full-Text Articles in Physical Sciences and Mathematics

Application Of Click Chemistry In The Development Of Peptide Based Hiv Fusion Inhibitors, Mukesh Madan Mudgal, Nagaraju Birudukota Nov 2018

Application Of Click Chemistry In The Development Of Peptide Based Hiv Fusion Inhibitors, Mukesh Madan Mudgal, Nagaraju Birudukota

Chemistry and Physics Faculty Articles

Human Immunodeficiency Virus (HIV) continues to be a major global public health issue. Inhibition of HIV envelope fusion with the CD4 cell membrane prevents the entry of HIV into the CD4 cells providing a novel approach to the treatment of HIV infection. Thus, interference in the fusion of the virus with the co-receptor substrate appears to be a specific and potential way to fight HIV infection and replication. Applications of click chemistry are spreading in the field of drug discovery and it became a powerful tool for the synthesis of medicinally important compounds.

Remarkably, the Cu (I)-Catalyzed Azide-Alkyne Cycloaddition (CuAAC) …


Applications Of Click Chemistry In The Development Of Hiv Protease Inhibitors, Mukesh Madan Mudgal, Nagaraju Birudukota, Mayur A. Doke Jul 2018

Applications Of Click Chemistry In The Development Of Hiv Protease Inhibitors, Mukesh Madan Mudgal, Nagaraju Birudukota, Mayur A. Doke

Chemistry and Physics Faculty Articles

Acquired Immunodeficiency Syndrome (AIDS) has been devastating for millions of people around the world. Inhibition of the human immunodeficiency virus (HIV) protease is among the most important approaches for the therapeutic intervention in HIV infection. Since the discovery of the HIV-1 protease, this enzyme has been considered as a key target for the inhibition of viral replication. A large body of research has been done to develop an effective HIV-1 protease inhibitor. There are to date 10 HIV-1 protease inhibitor drugs approved by the Food and Drug Administration (FDA) that have improved the survival and quality of life of HIV …